Key Events This Week
2 Mar: Stock opens with a sharp gap down amid market concerns
2 Mar: Downgrade to Strong Sell by MarketsMOJO due to weak financials and bearish technicals
4 Mar: Technical momentum shifts further bearish with deteriorating indicators
6 Mar: Week closes at Rs.699.45, down 3.31%

Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Bearish Signals
2026-03-04 08:07:21Aarti Pharmalabs Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite a recent weekly price gain, the stock’s overall technical profile and market performance suggest caution for investors amid weakening momentum and deteriorating technical grades.
Read full news article
Aarti Pharmalabs Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals
2026-03-03 09:03:36Aarti Pharmalabs Ltd has been downgraded from a Sell to a Strong Sell rating as of 2 March 2026, reflecting deteriorating fundamentals and bearish technical indicators. The downgrade follows a comprehensive reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals, signalling heightened caution for investors amid ongoing challenges in the pharmaceuticals sector.
Read full news article
Aarti Pharmalabs Ltd Opens with Significant Gap Down Amid Market Concerns
2026-03-02 13:34:37Aarti Pharmalabs Ltd commenced trading today with a pronounced gap down, opening at a price 7.31% lower than its previous close, reflecting heightened market apprehension. The stock’s weak start follows a series of mixed technical signals and a downgrade in its Mojo Grade, contributing to a cautious trading environment.
Read full news article
Aarti Pharmalabs Ltd is Rated Sell
2026-02-26 10:11:18Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Aarti Pharmalabs Ltd is Rated Sell
2026-02-15 10:10:45Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 February 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleAarti Pharmalabs Declines 8.95%: 4 Key Factors Behind the Weekly Slide
2026-02-14 10:01:14
Key Events This Week
9 Feb: Technical momentum shifts amid mixed indicator signals
10 Feb: Significant gap down opening and Q3 FY26 results released
12 Feb: Intraday low hit amid heavy price pressure
13 Feb: Week closes at Rs.708.00, down 8.95%

Aarti Pharmalabs Ltd Hits Intraday Low Amidst Price Pressure on 12 Feb 2026
2026-02-12 11:01:59Aarti Pharmalabs Ltd experienced a significant intraday decline on 12 Feb 2026, touching a low of Rs 694.5, reflecting a sharp price pressure of -7.78% during the trading session. The stock underperformed its sector and broader market indices, continuing a downward trend over the past three days.
Read full news articleAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
16-Feb-2026 | Source : BSETranscript of Q3 FY 26 Earnings Conference Call
Clarification Regarding Delay In Disclosure Of Event To The Exchange
13-Feb-2026 | Source : BSEPlease find enclosed
Announcement under Regulation 30 (LODR)-Newspaper Publication
11-Feb-2026 | Source : BSEPlease find enclosed
Corporate Actions
No Upcoming Board Meetings
Aarti Pharmalabs Ltd has declared 30% dividend, ex-date: 16 Feb 26
No Splits history available
No Bonus history available
No Rights history available







